Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-23T05:50:08.114Z Has data issue: false hasContentIssue false

Part III - The Treatment Plan

Published online by Cambridge University Press:  07 October 2023

Ethan O. Bryson  and
Christine E. Boxhorn
Ethan O. Bryson
Affiliation:
Icahn School of Medicine at Mount Sinai, New York
Christine E. Boxhorn
Affiliation:
Medical College of Wisconsin, Milwaukee
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The Opioid Epidemic
Origins, Current State and Potential Solutions
 , pp. 105 - 162
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References and Further Reading

American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). Washington, DC: American Psychiatric Association.Google Scholar
Alharbi, FF, Alsubaie, EG, Al-Surimi, K (2021). Substance abuse in Arab world: Does it matter and where are we? In Laher, I. (ed.) Handbook of Healthcare in the Arab World. Cham: Springer, pp. 2371–2398.CrossRefGoogle Scholar
Beletsky, L, Tomansini-Joshi, D (2019). ‘Treatment facilities’ aren’t what you think they are. New York Times, September 3.Google Scholar
Center for Substance Abuse Treatment (2006). Detoxification and Substance Abuse Treatment.Treatment Improvement Protocol (TIP) Series. No. 45. HHS Publication No. (SMA) 15–4131. Rockville, MD: Center for Substance Abuse Treatment.Google Scholar
Collins, ED, Kleber, HD, Whittington, RA, Heitler, NE (2005). Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: A randomized trial.JAMA 294(8): 903–913.Google Scholar
Connery, HS, McHugh, RK, Reilly, M, Shin, S, Greenfield, SF (2020). Substance use disorders in global mental health delivery: Epidemiology, treatment gap, and implementation of evidence-based treatments. Harvard Review of Psychiatry 28(5): 316–327.CrossRefGoogle ScholarPubMed
European Monitoring Centre for Drugs and Drug Addiction (2014). Residential treatment for drug use in Europe, EMCDDA Papers. Luxembourg: Publications Office of the European Union.Google Scholar
Forozeshfard, M, Hosseinzadeh Zoroufchi, B, Saberi Zafarghandi, MB, Bandari, R, Foroutan, B (2014). Six-month follow-up study of ultrarapid opiate detoxification with naltrexone. International Journal of High Risk Behaviors & Addiction 3(4):e20944.Google ScholarPubMed
Harm Reduction International (2018). Regional overview of the Middle East and North Africa. www.hri.global/files/2018/12/10/MiddleEastNorthAfrica-harm-reduction.pdfGoogle Scholar
Ivers, JH, Zgaga, L, Sweeney, B, et al. (2018). A naturalistic longitudinal analysis of post-detoxification outcomes in opioid-dependent patients. Drug and Alcohol Dependence 37(Suppl. 1): S339–S347.Google Scholar
McCorry, F, Garnick, GW, Bartlett, J, Cotter, F, Chalk, M (2000). Developing performance measures for alcohol and other drug services in managed care plans. Washington Circle Group. Joint Commission Journal on Quality Improvement 26(11): 633–643.Google ScholarPubMed
Mee-Lee, D, Shulman, GD, Fishman, MJ, Gastfriend, DR, Miller, MM (2013). The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, 3rd ed. Carson City, NV: The Change Companies.Google Scholar
O’Malley, GF and O’Malley, R (2020). Opioid toxicity and withdrawal. Merck manual, professional version. www.msdmanuals.com/professional/special-subjects/illicit-drugs-and-intoxicants/opioid-toxicity-and-withdrawal/?autoredirectid=20985Google Scholar
Olsen, JP, Walden, L (2008). The Narcotic Farm [Video]. King Love Films and the Independent Television Service. https://vimeo.com/91392115Google Scholar
Reif, S, George, P, Braude, L (2014). Residential treatment for individuals with substance use disorder: Assessing the evidence. Psychological Services 65(3): 301–312.Google Scholar
Substance Abuse and Mental Health Services Administration (2021). National Survey of Substance Abuse Treatment Services (N-SSATS): 2020. Data on Substance Abuse Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration.Google Scholar
Turner, A (2015). Alternatives to criminalizing public intoxication: Case study of a sobering centre in Calgary, AB. SPP Research Papers 1–8(27).Google Scholar
United Nations Office on Drugs and Crime (2022). Compulsory Drug Treatment and Rehabilitation in East and Southeast Asia: Executive Summary. Bangkok, Thailand: UNODC Regional Office for Southeast Asia and the Pacific.Google Scholar
Wesson, DR, Ling, W (2003). The clinical opiate withdrawal scale. Journal of Psychoactive Drugs 35(2): 253–259.CrossRefGoogle ScholarPubMed
World Health Organization and United Nations Office on Drugs and Crime (2020). International Standards for the Treatment of Drug Use Disorders: Revised Edition Incorporating Results of Field-Testing. Geneva, Switzerland: WHO and UNODC.Google Scholar
Wright, TM, Cluver, JS, Myrick, H (2014). Management of intoxication and withdrawal: General principles. In Ries, RK, Fiellin, DA, Miller, SC, Saitz, R (eds.) The ASAM Principles of Addiction Medicine, 5th ed. Philadelphia, PA: Wolters Kluwer, pp. 625–634.Google Scholar
Yassini Ardekani, SM, Yassini Ardekani, S (2013). Ultrarapid opioid detoxification: Current status in Iran and controversies. International Journal of High Risk Behaviors & Addiction 2(3): 96–99. https://doi.org/10.5812/ijhrba.13140Google Scholar

References and Further Reading

Alam, DA, Martorana, A (2011). Addiction treatment: Level of care determination. Primary Care: Clinics in Office Practice 38: 125–136.CrossRefGoogle ScholarPubMed
Center for Substance Abuse Treatment (2006). Detoxification and Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series. No. 45. HHS Publication No. (SMA) 15–4131. Rockville, MD: Center for Substance Abuse Treatment.Google Scholar
Eddie, D, Vaschillo, E, Vaschillo, B, Lehrer, P (2015). Heart rate variability biofeedback: Theoretical basis, delivery, and its potential for the treatment of substance use disorders. Addiction Research and Theory 23(4): 266–272.CrossRefGoogle ScholarPubMed
Han, J, Cui, C, Wu, L (2011). Acupuncture-related techniques for the treatment of opiate addiction: A case of translational medicine. Frontiers of Medicine 5(2): 141–150.CrossRefGoogle ScholarPubMed
Kurtz, E, White, W (2003). Alcoholics Anonymous. In Blocker, J, Tyrell, I (eds.) Alcohol and Temperance in Modern History. Santa Barbara, CA: ABC-CLIO, pp. 27–31.Google Scholar
Lo Coco, G, Melchiori, F, Oien, V, et al. (2019). Group treatment for substance use disorders in adults: A systematic review and meta-analysis of randomized-controlled trials. Journal of Substance Abuse Treatment 99: 104–116.CrossRefGoogle ScholarPubMed
McCarty, D, Braude, L, Lyman, DR, et al. (2014). Substance abuse intensive outpatient programs: Assessing the evidence. Psychiatric Services 65(6): 718–726.Google Scholar
Substance Abuse and Mental Health Services Administration (2021). Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders. SAMHSA Publication No. PEP21-06–02–001. Rockville, MD: Substance Abuse and Mental Health Services Administration.Google Scholar
Tice, JA, Whittington, MD, Fluetsch, N, et al. (2020). Health technologies as an adjunct to medication assisted therapy for opioid use disorder: Evidence report. Institute for Clinical and Economic Review. https://icer.org/wp-content/uploads/2020/08/ICER_Digital_Therapeutics_for_OUD_Evidence_Report.pdfGoogle Scholar
Tsamitros, N, Sebold, M, Gutwinski, S, et al. (2021). Virtual reality-based treatment approaches in the field of substance use disorders. Current Addiction Reports 8: 399–407.Google Scholar
White, W, Budnick, C, Pickard, B (2011). Narcotics Anonymous: Its history and culture. Counselor, 12(2), 10–15, 22–27, 36–39, 46–50. https://counselormagazine.com/en/columns/2013/columns/narcotics-anonymous/Google Scholar

References and Further Reading

Beetham, T, Saloner, B, Gaye, M, et al. (2021). Admission practices and cost of care for opioid use disorder at residential addiction treatment programs in the US. Health Affairs (Millwood) 40(20): 317–325.CrossRefGoogle ScholarPubMed
European Monitoring Centre for Drugs and Drug Addiction (2011). Cost and Financing of Drug Treatment Services in Europe: An Exploratory Study. Luxembourg: Publications Office of the European Union.Google Scholar
French, MT, Salome, HJ, Carney, M (2002). Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington. Social Science & Medicine 55: 2267–2282.CrossRefGoogle ScholarPubMed
Hall, NY, Le, L, Majmudar, I, Mihalopoulos, C (2021). Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence 221: 108651.Google Scholar
Lievens, D, Vander Laenen, F, Christiaens, J (2014). Public spending for illegal drug and alcohol treatment in hospitals: An EU cross-country comparison. Substance Abuse Treatment, Prevention, and Policy 9: 26.CrossRefGoogle ScholarPubMed
Lohse, J, Ashpole, L, Epperson, KJ (2018). Behavioral health care: The new frontier of fraud and abuse? AHLA Connections. sharepoint.healthlawyers.org/News/Connections/Documents/2018/Feature/January-February2018_Feature1.pdf.Google Scholar
Moore, TJ, Ritter, A. Caulkins, JP (2007). The costs and consequences of three policy options for reducing heroin dependency. Drug and Alcohol Review 26: 369–378.Google Scholar
Priester, MA, Browne, T, Iachini, A, et al. (2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review. Journal of Substance Abuse Treatment 61: 47–59.CrossRefGoogle ScholarPubMed
Recovery Centers of America (2020). Economic cost of substance abuse Disorder in the United States, 2019. http://recoverycentersofamerica.com/resource/economic-cost-of-substance-abuse-disorder-in-united-states-2019/.Google Scholar
Reif, S, George, P, Braude, L (2014). Residential treatment for individuals with substance use disorder: assessing the evidence. Psychological Services 65(3): 301–312.CrossRefGoogle ScholarPubMed
Reif, S, Creedon, TB, Horgan, CM, Stewart, MT, Garnick, DW (2017). Commercial health plan coverage of selected treatments for opioid use disorders from 2003 to 2014. Journal of Psychoactive Drugs 49(2): 102–110.Google Scholar
Ruger, JP, Chawarski, M, Mazlan, M, et al. (2012). Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide. Health Research Educational Trust 47(2): 865–887.Google ScholarPubMed
Seville, LR, Schecter, A, Rappleye, H (2017). Florida’s billion-dollar drug treatment industry is plagued by overdoses, fraud. NBC News.www.nbcnews.com/feature/megyn-kelly/florida-s-billion-dollar-drug-treatment-industry-plagued-overdoses-fraud-n773376.Google Scholar
Substance Abuse and Mental Health Services Administration (2020). Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. HHS Publication No. PEP20-07–01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.Google Scholar
Substance Abuse and Mental Health Services Administration (2021). National Survey of Substance Abuse Treatment Services (N-SSATS): 2020. Data on Substance Abuse Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration.Google Scholar
US Department of Health and Human Services(2016). Office of the Surgeon General, Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: US Department of Health and Human Services.Google Scholar
US Department of Health and Human Services (2018). Facing Addiction in America: The Surgeon General’s Spotlight on Opioids. Washington, DC: US Department of Health and Human Services.Google Scholar

References and Further Reading

Bernard, CL, Rao, IJ, Robison, KK, Brandeau, ML, (2020). Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: a model-based analysis. PLoS Medicine 17(10): e1003239.Google Scholar
Bond, AJ, Witton, J (2017). Perspectives on the pharmacologic treatment of heroin addiction. Clinical Medicine Insights: Psychiatry 8: 1–10.Google Scholar
Canadian Centre on Substance Use and Addiction (2021). Evidence-based decriminalization (policy brief). www.ccsa.ca/evidence-based-decriminalization-policy-brief.Google Scholar
Centers for Disease Control and Prevention (2019). Summary of information on the safety and effectiveness of syringe services programs (SSPs). www.cdc.gov/ssp/syringe-services-programs-summary.html.Google Scholar
Cropsey, KL, Schiavon, SP (2019). Criminal justice system and addiction treatment. In Johnson, B (ed.) Addiction Medicine: Science and Practice, 2nd ed. Elsevier, pp. 628–637.Google Scholar
Dole, VP, Nyswander, M (1965). A medical treatment for diacetylmorphine (heroin) addiction. JAMA 193(8): 80–84.CrossRefGoogle ScholarPubMed
European Monitoring Centre for Drugs and Drug Addiction (2020) Take home naloxone, factsheet. www.emcdda.europa.eu/publications/topic-overviews/take-home-naloxone_en.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction (n.d.). Drug court programmes to reduce recidivism. www.emcdda.europa.eu/best-practice/evidence-summaries/drug-court-programmes-reduce-recidivism_en.Google Scholar
Goldman, JE, Waye, KM, Periera, KA, et al. (2019). Perspectives on rapid fentanyl testing strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduction Journal 16: 3.Google Scholar
Gugala, E, Briggs, O, Moczygemba, LR, Brown, CM, Hill, LG (2022). Opioid harm reduction: A scoping review of physician and system-level gaps in knowledge, education, and practice. Substance Abuse 43(1): 972–987.Google Scholar
Harm Reduction International (2018). Regional overview of the Middle East and North Africa. www.hri.global/files/2018/12/10/MiddleEastNorthAfrica-harm-reduction.pdf.Google Scholar
Indiana State Department of Health (n.d.). Naloxone myths debunked. www.in.gov/health/overdose-prevention/files/47_naloxone-myths-debunked.pdf.Google Scholar
Jaffe, JH (2007). Can LAAM, like Lazarus, come back from the dead? Addiction 102: 1342–1343.CrossRefGoogle ScholarPubMed
Jesseman, R, Payer, D (2018). Decriminalization: Options and evidence. Canadian Centre on Substance Use and Addiction Policy Brief. 6/2018. www.ccsa.ca/sites/default/files/2019-04/CCSA-Decriminalization-Controlled-Substances-Policy-Brief-2018-en.pdf.Google Scholar
Klaman, SL, Isaacs, K, Leopold, A, et al. (2019). Treatment women who are pregnant and parenting for opioid use disorder and the concurrent care of infants and children: Literature review to support national guidance. Journal of Addiction Medicine 11(3): 178–190.CrossRefGoogle Scholar
Kounang, N (2021). This strip of paper can help prevent a drug overdose. CNN Health, December 1. http://edition.cnn.com/2021/12/01/health/fentanyl-test-strip/index.html.Google Scholar
Levengood, TW, Yoon, GH, Davoust, MJ, et al. (2021). Supervised injection facilities as harm reduction: A systematic review. American Journal of Preventive Medicine 61(5): 738–749.Google Scholar
Lofwall, MR, Walsh, SL (2014). A review of buprenorphine diversion and misuse: The current evidence base and experiences from around the world. Journal of Addiction Medicine 8(5): 315–326.CrossRefGoogle ScholarPubMed
Macpherson, D (2001). Framework for action: A four-pillar approach to drug problems in Vancouver. www.researchgate.net/publication/242480594_A_Four-Pillar_Approach_to_Drug_Problems_in_Vancouver.Google Scholar
Mielau, J, Vogel, M, Gutwinski, S, Mick, I (2021). New approaches in drug dependence: Opioids. Current Addiction Reports 8(2): 298–305.CrossRefGoogle ScholarPubMed
Miller, A (2022). As overdoses soar, more states decriminalize fentanyl testing strips. https://khn.org/news/article/states-decriminalize-fentanyl-testing-strips/.Google Scholar
Moaleff, S, Choi, J, Milloy, MJ, et al. (2021). A drug-related Good Samaritan law and calling emergency services for drug overdoses in a Canadian setting. Harm Reduction Journal 18: 91.Google Scholar
Moosavyzadeh, A, Mokri, A, Ghaffari, F, et al. (2020). Hab-o Shefa, a Persian medicine compound for maintenance treatment of opioid dependence: Randomized placebo-controlled clinical trial. Journal of Alternative and Complementary Medicine 26(5): 376–383.Google Scholar
National Institute on Drug Abuse (2017). Naloxone for opioid overdose: Life-saving science. https://nida.nih.gov/publications/naloxone-opioid-overdose-life-saving-science.Google Scholar
Noroozi, A, Kebriaeezadeh, A, Mirrahimi, B, et al. (2021). Opium tincture-assisted treatment for opioid use disorder: A systematic review. Journal of Substance Abuse 129: 108519.CrossRefGoogle ScholarPubMed
Rosenstein, RJ (2018). Fight drug abuse, don’t subsidize it. New York Times, August 27. www.nytimes.com/2018/08/27/opinion/opioids-heroin-injection-sites.html.Google Scholar
Rossman, SB, Rempel, M, Zweig, JM, Rempel, M , Lindquist, CH (2011). The Multi-Site Adult Drug Court Evaluation: The Impact of Drug Courts, volume 4. Washington, DC: National Institute of Justice.Google Scholar
Sander, G, Shirley-Beavan, S. Stone, K (2019). The global state of harm reduction in prisons. Journal of Correctional Health Care 25(2): 105–120.Google Scholar
Scott, CK, Dennis, ML, Grella, CE, Mischel, AF, Carnevale, J (2021). The impact of the opioid crisis on U.S. state prison systems. Health and Justice 9: 17.Google Scholar
Shulman, M, Wai, JM, Nunes, EV (2019). Buprenorphine treatment for opioid use disorder: An overview. CNS Drugs 33(6): 567–580.CrossRefGoogle ScholarPubMed
Sofuoglu, M, DeVito, EE, Carroll, KM (2019). Pharmacologic and behavioral treatment of opioid use disorder. Psychiatric Research and Clinical Practice 1(1): 4–15.Google Scholar
Substance Abuse and Mental Health Services Administration (2021). Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63 Publication No. PEP21-02–01–002. Rockville, MD: Substance Abuse and Mental Health Services Administration.Google Scholar
Surratt, HL, Otachi, JK, Williams, T, et al. (2020). Motivation to change and treatment participation among syringe service program utilizers in rural Kentucky. Journal of Rural Health 36(2): 224–233. doi:10.1111/jrh.12388.Google Scholar
United Nations Office on Drugs and Crime (2006). Drug treatment courts work! www.unodc.org/pdf/drug_treatment_courts_flyer.pdf.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • The Treatment Plan
  • Ethan O. Bryson, Icahn School of Medicine at Mount Sinai, New York, Christine E. Boxhorn, Medical College of Wisconsin, Milwaukee
  • Book: The Opioid Epidemic
  • Online publication: 07 October 2023
  • Chapter DOI: https://doi.org/10.1017/9781009256551.013
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • The Treatment Plan
  • Ethan O. Bryson, Icahn School of Medicine at Mount Sinai, New York, Christine E. Boxhorn, Medical College of Wisconsin, Milwaukee
  • Book: The Opioid Epidemic
  • Online publication: 07 October 2023
  • Chapter DOI: https://doi.org/10.1017/9781009256551.013
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • The Treatment Plan
  • Ethan O. Bryson, Icahn School of Medicine at Mount Sinai, New York, Christine E. Boxhorn, Medical College of Wisconsin, Milwaukee
  • Book: The Opioid Epidemic
  • Online publication: 07 October 2023
  • Chapter DOI: https://doi.org/10.1017/9781009256551.013
Available formats
×